• Je něco špatně v tomto záznamu ?

A composite device for viscosupplementation treatment resistant to degradation by reactive oxygen species and hyaluronidase

E. Toropitsyn, M. Pravda, D. Rebenda, I. Ščigalková, M. Vrbka, V. Velebný

. 2022 ; 110 (12) : 2595-2611. [pub] 20220621

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032502

Osteoarthritis (OA) is one of the most common musculoskeletal disorders in the world. OA is often associated with the loss of viscoelastic and tribological properties of synovial fluid (SF) due to degradation of hyaluronic acid (HA) by reactive oxygen species (ROS) and hyaluronidases. Viscosupplementation is one of the ways how to effectively restore SF functions. However, current viscosupplementation products provide only temporal therapeutic effect because of short biological half-life. In this article we describe a novel device for viscosupplementation (NV) based on the cross-linked tyramine derivative of HA, chondroitin sulfate (CS), and high molecular weight HA by online determination of viscoelastic properties loss during degradation by ROS and hyaluronidase. Rheological and tribological properties of developed viscosupplement were compared with HA solutions with different molecular weights in the range 500-2000 kDa, which are currently commonly used as medical devices for viscosupplementation treatment. Moreover, based on clinical practice and scientific literature all samples were also diluted by model OA SF in the ratio 1:1 (vol/vol) to better predict final properties after injection to the joint. The observed results confirmed that NV exhibits appropriate rheological properties (viscosity, elastic, and viscous moduli) comparable with healthy SF and maintain them during degradation for a significantly longer time than HA solutions with molecular weight in the range 500-2000 kDa and cross-linked material without CS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032502
003      
CZ-PrNML
005      
20230131151244.0
007      
ta
008      
230120s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jbm.b.35114 $2 doi
035    __
$a (PubMed)35727166
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Toropitsyn, Evgeniy $u Contipro a.s., Dolní Dobrouč, Czech Republic $u Biocev, First Faculty of Medicine Charles University, Vestec, Czech Republic $1 https://orcid.org/0000000322031150
245    12
$a A composite device for viscosupplementation treatment resistant to degradation by reactive oxygen species and hyaluronidase / $c E. Toropitsyn, M. Pravda, D. Rebenda, I. Ščigalková, M. Vrbka, V. Velebný
520    9_
$a Osteoarthritis (OA) is one of the most common musculoskeletal disorders in the world. OA is often associated with the loss of viscoelastic and tribological properties of synovial fluid (SF) due to degradation of hyaluronic acid (HA) by reactive oxygen species (ROS) and hyaluronidases. Viscosupplementation is one of the ways how to effectively restore SF functions. However, current viscosupplementation products provide only temporal therapeutic effect because of short biological half-life. In this article we describe a novel device for viscosupplementation (NV) based on the cross-linked tyramine derivative of HA, chondroitin sulfate (CS), and high molecular weight HA by online determination of viscoelastic properties loss during degradation by ROS and hyaluronidase. Rheological and tribological properties of developed viscosupplement were compared with HA solutions with different molecular weights in the range 500-2000 kDa, which are currently commonly used as medical devices for viscosupplementation treatment. Moreover, based on clinical practice and scientific literature all samples were also diluted by model OA SF in the ratio 1:1 (vol/vol) to better predict final properties after injection to the joint. The observed results confirmed that NV exhibits appropriate rheological properties (viscosity, elastic, and viscous moduli) comparable with healthy SF and maintain them during degradation for a significantly longer time than HA solutions with molecular weight in the range 500-2000 kDa and cross-linked material without CS.
650    _2
$a chondroitin sulfáty $x farmakologie $7 D002809
650    _2
$a lidé $7 D006801
650    _2
$a kyselina hyaluronová $x farmakologie $7 D006820
650    _2
$a hyaluronoglukosaminidasa $x terapeutické užití $7 D006821
650    _2
$a injekce intraartikulární $7 D007270
650    12
$a osteoartróza $x farmakoterapie $7 D010003
650    12
$a artróza kolenních kloubů $7 D020370
650    _2
$a reaktivní formy kyslíku $7 D017382
650    _2
$a tyramin $x terapeutické užití $7 D014439
650    12
$a viskosuplementace $x metody $7 D055676
650    _2
$a viskoelastické doplňky kloubní tekutiny $x terapeutické užití $7 D055675
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pravda, Martin $u Contipro a.s., Dolní Dobrouč, Czech Republic
700    1_
$a Rebenda, David $u Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic
700    1_
$a Ščigalková, Ivana $u Contipro a.s., Dolní Dobrouč, Czech Republic
700    1_
$a Vrbka, Martin $u Faculty of Mechanical Engineering, Brno University of Technology, Brno, Czech Republic
700    1_
$a Velebný, Vladimír $u Contipro a.s., Dolní Dobrouč, Czech Republic
773    0_
$w MED00007497 $t Journal of biomedical materials research. Part B, Applied biomaterials $x 1552-4981 $g Roč. 110, č. 12 (2022), s. 2595-2611
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35727166 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151240 $b ABA008
999    __
$a ok $b bmc $g 1891327 $s 1183837
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 110 $c 12 $d 2595-2611 $e 20220621 $i 1552-4981 $m Journal of biomedical materials research. Part B, Applied biomaterials $n J Biomed Mater Res $x MED00007497
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace